The Greek-American entrepreneur embodying the American Dream made waves with his latest donation of $400 million to the ...

A 1954 graduate of Columbia, Dr. Vagelos significantly contributed to developing statin drugs that lower cholesterol during his tenure as chief executive at Merck. Under his leadership, the company ...

UFAR and its partners use the community-directed treatment with ivermectin (CDTI) approach recommended by ... Pharmaceutical Regulatory Affairs Scientist, Merck & Co., Inc.) An advisory council ...

A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 5.6% over the past three months. But if you pay close attention, you might find that ...

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...

In 2021, the FDA blasted Merck for using a premature endpoint to pursue a Keytruda approval in early-stage triple-negative breast cancer (TNBC). Now, the PD-1 inhibitor has gold-standard overall ...

RAHWAY, N.J., August 29, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided updates on two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630.

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

To keep your pup safe from heartworm disease and its serious repercussions, review our researched list of the best heartworm ...